STAT Plus: Gilead Sciences to lay off one-fifth of sales force as financial pressures build
PAUL SAKUMA/AP
The employees affected work in Gilead’s cardiopulmonary sales division, which currently markets two products that have lost patent protection.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario